
HRMY P/E Ratio
P/E Ratio as of Jul 2, 2025: 12.24
Average12.72
Median12.46
Minimum12.04
Maximum13.67
12.24
Past Month-0.91 (6.92%)
The P/E ratio for HRMY is 12.24 as of Jul 2, 2025. This represents a decrease of -21.03% compared to its 12-month average P/E ratio of 15.5. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Harmony Biosciences Holdings P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Harmony Biosciences Holdings’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Harmony Biosciences Holdings to industry peers.
Harmony Biosciences Holdings P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Harmony Biosciences Holdings’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Harmony Biosciences Holdings to industry peers.
HRMY P/E Ratio Insights
See Harmony Biosciences Holdings’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in HRMY
Order type
Buy in
Order amount
Est. shares
0 shares
HRMY P/E Ratio Historic Data
Date | Stock price | P/E ratio |
---|---|---|
Jul 1, 2025 | $32.03 | 12.21 |
Jun 2, 2025 | $35.56 | 13.56 |
May 1, 2025 | $29.86 | 11.90 |
Apr 1, 2025 | $32.42 | 12.92 |
Mar 3, 2025 | $32.18 | 12.82 |
Feb 3, 2025 | $38.70 | 18.32 |
Jan 2, 2025 | $34.83 | 16.49 |
HRMY End of Year P/E Ratio
Date | P/E ratio | Change |
---|---|---|
2025 | 12.24 | -24.86% |
2024 | 16.29 | +24.45% |
2023 | 13.09 | -39.31% |
2022 | 21.57 | -70.84% |
2021 | 73.96 | -306.82% |
2020 | -35.76 | — |
FAQs About Harmony Biosciences Holdings (HRMY) P/E ratio
The latest P/E ratio of HRMY is 12.24, as of Jul 2, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Harmony Biosciences Holdings’s last 12-month average P/E ratio is 15.5, compared to its current P/E ratio of 12.24. This reflects a decrease of -21.03%.
Harmony Biosciences Holdings’s current P/E ratio of 12.24 is lower than its last 12-month average P/E of 15.5. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Harmony Biosciences Holdings’s average P/E ratio over the last 3 years is 16.62. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Harmony Biosciences Holdings’s average P/E ratio over the last 5 years is 16.28. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.